Global Longitudinal Strain for Prognostic Staging in Wild Type Transthyretin Cardiac Amyloidosis
Presenters: Dr. Eve CARIOU - Cardiologist, Toulouse University Hospital Global Longitudinal Strain for Prognostic Staging in Wild-Type Transthyretin Cardiac Amyloidosis https://pubmed.ncbi.nlm.nih.gov/41342... Dr. Jean-Pierre GUEFFET - Cardiologist, Confluent Private Hospital - Nantes Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance. https://pubmed.ncbi.nlm.nih.gov/40643... Moderators: Dr. Emmanuelle BERTHELOT - Deputy Head of Department, Cardiologist - APHP Bicêtre University Hospital - Le Kremlin-Bicêtre Dr. Florian ZORES - Cardiologist, Ellipse Center - Strasbourg

▶︎
Transthyretin amyloid cardiomyopathy natural history and treatment response assessed by cardiovas...

▶︎
Gourmet Coffee - Infectious Risk Prevention Updates Training Institutes (June 11, 2026)

▶︎
Should stage II stomach cancer be treated with chemotherapy?

▶︎
Prognostic role of cardiopulmonary exercise testing in wild type transthyretin amyloid cardiomyopath

▶︎
Amylose - Vidéo explicative

▶︎
Bibliose, June 4, 2026

▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

▶︎
The World's Most Important Machine

▶︎
But what is quantum computing? (Grover's Algorithm)

▶︎
Rendez-vous digital "Péri-habilitation en oncogériatrie" OncoPaca-Corse, UCOG Paca-Ouest et Paca-Est

▶︎
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With T

▶︎
How to Speak Clearly & With Confidence | Matt Abrahams

▶︎
Nervous System Regulation (999 Hz) | 1 hour handpan music | Malte Marten

▶︎
Jeudi Onco Occitanie #34 Interventions non médicamenteuses et niveau de preuve

▶︎
UN Medical Insurance Plan en français 20260611 120042UTC Meeting Recording

▶︎
I Used 100% CASTOR OIL Eye Drops for 30 days - Here's What happened

▶︎
Bibliose du 21 Mai 2026

▶︎
Webinaire CRATB RSQR Antibiothérapie 16/06/2026

▶︎
Development and Validation of a Risk Score for Transthyretin Amyloidosis in Patients with Severe Aor

▶︎
